• We value nothing
    more important than life
  • Making a difference in life,
    Creating a healthier future
  • Accelerate drug development,
    Make drugs work

1 ⁄ 3

Who we are
스크롤

Mission

At Oncocross, we strive to develop drugs that can satisfy unmet medical needs through our AI platform. ONCO AI allows rare disease patients to receive the best treatment and partners to accelerate research and drug development. ONCOfind AI detects primary site of cancer with high accuracy. Accelerate drug development with Oncocross in less time with low cost.

Milestone

  • Cancer Research UK

    Material Transfer
    Agreement

    Sep 2020

  • Series B Funding

    KRW
    16,500,000,000

    Aug 2020

  • Columbia University
    Medical Center

    Research Collaboration

    Aug 2020

  • Boehringer
    Ingelheim

    Research Collaboration

    Jul 2020

  • Korea Pharma

    License Out

    Jun 2020

  • Merck Accelerator
    Program

    Final Round Bootcamp

    Jun 2020

  • Ministry of SMEs
    and Startups

    BIG3

    May 2020

  • Jeil Pharmaceutical

    License In

    Jan 2020

  • Ministry of Health
    and Welfare

    표창장

    Oct 2019

  • Series A Funding

    KRW
    6,000,000,000

    May 2019
contactUs

Contact Us

  • 전화번호

    TEL

    +82-2-867-9967

  • 이메일

    E-MAIL

    oncocross
    @oncocross.com

  • 팩스

    FAX

    +82-2-867-9968

  • 주소

    ADDRESS

    16F Gongdeok Bldg, Saechang-ro 11,
    Mapo-gu, Seoul, Korea